Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psoriasis Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02470481
What this trial is testing

A Study in Participants With Psoriatic Arthritis Attending Dermatology Clinics

Who this might be right for
Psoriatic Arthritis
Janssen Research & Development, LLC 250
Post-approval studies (Phase 4)Study completedNCT00312026
What this trial is testing

Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Plaque Psoriasis Involving the Hands and/or Feet

Who this might be right for
Psoriasis
Genentech, Inc. 75
Not applicableStudy completedNCT01768858
What this trial is testing

Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice

Who this might be right for
Rheumatoid ArthritisAnkylosing SpondylitisPsoriatic Arthritis+3 more
AbbVie 96
Early research (Phase 1)Study completedNCT00220025
What this trial is testing

Narrowband UVB Light Therapy to Patients With Dark Skin Types Who Have 10% of Their Body Involved With Psoriasis Vulgaris.

Who this might be right for
Psoriasis Vulgaris
Mary Sullivan-Whalen 70
Not applicableLooking for participantsNCT04080635
What this trial is testing

Therapeutic Drug Monitoring of Brodalumab in Psoriasis Patients (BIOLOPTIM-BRO)

Who this might be right for
Psoriasis Vulgaris
University Hospital, Ghent 100
Post-approval studies (Phase 4)Study completedNCT01722214
What this trial is testing

Trial on the Effect of Adalimumab on Vascular Inflammation in Patients With Psoriasis

Who this might be right for
PsoriasisVascular InflammationCoronary Atherosclerosis
Innovaderm Research Inc. 107
Large-scale testing (Phase 3)Study completedNCT01597245
What this trial is testing

Study in Participants With Moderate to Severe Psoriasis (UNCOVER-2)

Who this might be right for
Psoriasis
Eli Lilly and Company 1,224
Large-scale testing (Phase 3)Ended earlyNCT01694264
What this trial is testing

Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα

Who this might be right for
Chronic Hepatitis BRheumatoid ArthritisAnkylosing Spondylitis+2 more
Seoul National University Hospital 43
Testing effectiveness (Phase 2)WithdrawnNCT01200264
What this trial is testing

Apremilast for Chronic Plaque Psoriasis (CPP) Patients Who Have Failed One Course of Biologic Therapy

Who this might be right for
Chronic Plaque Psoriasis
Duke University
Not applicableUnknownNCT05084417
What this trial is testing

A Prospective, Observational Study of Clinician and Patient-reported Outcomes in Patients With Dermatological Conditions

Who this might be right for
Atopic DermatitisDermatologyVitiligo+3 more
OM1, Inc. 10,000
Not applicableAvailableNCT04159597
What this trial is testing

Expanded Access to Upadacitinib

Who this might be right for
Crohn DiseaseUlcerative ColitisIdiopathic Arthritis (Including sJIA, pJIA, or JPsA)+11 more
AbbVie
Post-approval studies (Phase 4)Study completedNCT05080218
What this trial is testing

COVID-19 VaccinE Response in Rheumatology Patients

Who this might be right for
Rheumatoid ArthritisPsoriatic ArthritisSpondylarthritis
Jeffrey Curtis 841
Large-scale testing (Phase 3)Study completedNCT02310646
What this trial is testing

Patient Insights Following Use of LEO 90100 Aerosol Foam and Daivobet® Gel in Subjects With Psoriasis Vulgaris

Who this might be right for
Psoriasis Vulgaris
LEO Pharma 219
Not applicableStudy completedNCT03339089
What this trial is testing

Real-world Effectiveness of Adalimumab on Health Outcomes in Chinese Patients With Immune-Mediated Inflammatory Diseases

Who this might be right for
Ankylosing Spondylitis (AS)PsoriasisRheumatoid Arthritis (RA)
AbbVie 224
Not applicableStudy completedNCT05344482
What this trial is testing

Evaluation of the Effectiveness of Secukinumab in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 277
Testing effectiveness (Phase 2)Study completedNCT05295979
What this trial is testing

Chinese Medicine for Patients With Psoriasis

Who this might be right for
Psoriasis
Chinese University of Hong Kong 60
Not applicableLooking for participantsNCT06533423
What this trial is testing

Effect of a Self-Management Intervention for Patients Newly Diagnosed With Inflammatory Arthritis: The NISMA Trial

Who this might be right for
Inflammatory Arthritis
Glostrup University Hospital, Copenhagen 130
Testing effectiveness (Phase 2)Study completedNCT04015518
What this trial is testing

Test How Effective and Safe Different Doses of BI 655130 Are in Patients With a Moderate to Severe Form of the Skin Disease Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis (PPP)
Boehringer Ingelheim 152
Large-scale testing (Phase 3)WithdrawnNCT01527097
What this trial is testing

Influence of Atorvastatin on Psoriasis Severity and Endothelial Function

Who this might be right for
Psoriasis
shmuel fuchs
Testing effectiveness (Phase 2)Study completedNCT01837420
What this trial is testing

Evaluate the Efficacy and Safety of VB-201 in Patients With Psoriasis

Who this might be right for
Psoriasis
Vascular Biogenics Ltd. operating as VBL Therapeutics 194
Next Page